Hypophosphatemia

Last updated: February 23, 2023

Hypophosphatemia

Renal

Renal

Development of the renal system
Potter sequence
Horseshoe kidney
Renal agenesis
Multicystic dysplastic kidney
Posterior urethral valves
Renal system anatomy and physiology
Body fluid compartments
Glomerular filtration
Renal clearance
Regulation of renal blood flow
Movement of water between body compartments
Tubular secretion of PAH
Tubular reabsorption of glucose
Proximal convoluted tubule
Loop of Henle
Distal convoluted tubule
Osmoregulation
Urea recycling
Renin-angiotensin-aldosterone system
Measuring renal plasma flow and renal blood flow
Erythropoietin
Hyperkalemia
Hypokalemia
Hypernatremia
Hyponatremia
Hypermagnesemia
Hypomagnesemia
Hyperphosphatemia
Hypophosphatemia
Hypercalcemia
Hypocalcemia
Hyperaldosteronism
Physiologic pH and buffers
Acid-base map and compensatory mechanisms
Plasma anion gap
Metabolic acidosis
Metabolic alkalosis
Respiratory acidosis
Respiratory alkalosis
The role of the kidney in acid-base balance
Renal tubular acidosis
Kidney stones
Hydronephrosis
Vesicoureteral reflux
Urinary incontinence: Pathology review
Neurogenic bladder
Poststreptococcal glomerulonephritis
Rapidly progressive glomerulonephritis
Goodpasture syndrome
Lupus nephritis
IgA nephropathy (NORD)
Alport syndrome
Membranoproliferative glomerulonephritis
Minimal change disease
Focal segmental glomerulosclerosis (NORD)
Membranous nephropathy
Diabetic nephropathy
Urinary tract infections (UTIs): Nursing process (ADPIE)
Urinary tract infections: Pathology review
Acute kidney injury: Clinical
Renal azotemia
Prerenal azotemia
Postrenal azotemia
Renal cortical necrosis
Chronic kidney disease
Renal artery stenosis
Angiomyolipoma
Renal cysts and cancer: Clinical
Polycystic kidney disease
Medullary cystic kidney disease
Renal cell carcinoma
WAGR syndrome
Non-urothelial bladder cancers
Transitional cell carcinoma
Renal and urinary tract masses: Pathology review
Loop diuretics
Thiazide and thiazide-like diuretics
Hyperkalemia: Clinical
ACE inhibitors, ARBs and direct renin inhibitors

Transcript

Watch video only

Hypo- means under, phosphat- refers to phosphate, and -emia refers to the blood, so hypophosphatemia means having a low phosphate level in the blood, typically below 2.5mg/dL.

Phosphate is made up of one central phosphorus atom surrounded by four oxygen atoms in a tetrahedral arrangement, like a mini pyramid, and has a charge of minus 3 and is written PO43-.

In the body, about 85% of the phosphate is stored in the bones, where it combines with calcium to make a tough compound called hydroxyapatite which is the stuff that makes bones hard.

Of the remaining phosphate, a tiny amount is extracellular, or outside cells like in the blood, so this is the bit that gets measured, and the majority is intracellular, or inside cells, where it does all sorts of things.

It’s responsible for phosphorylation, where it binds to fats and proteins.

It forms the high energy bonds of adenosine triphosphate or ATP, which is the most common energy currency in the cell.

It’s part of the DNA and RNA backbone that links individual nucleotides together, and is also part of cellular signaling molecules like cyclic-adenosine monophosphate or cAMP.

Bottom line - phosphate is super important.

Because most of the phosphate is locked up with calcium in the bones, the levels of phosphate are heavily tied with the levels of ionized calcium in the body.

If calcium levels fall, the four parathyroid glands buried within the thyroid gland release parathyroid hormone which frees up both calcium and phosphate ions from the bones.

It does this by stimulating osteoclasts, the cells that break bone down, to release hydrogen ions which dissolves the hard, mineralized hydroxyapatite.

As soon as the positively-charged calcium and negatively-charged phosphate are released from the bones, they grab onto each other again like a pair of star-crossed lovers, meaning that the ionized calcium level doesn’t really go up very much at all.

Now, these two make their way to the nephron of the kidney, and at this point in the proximal convoluted tubule, phosphate usually gets reabsorbed back into the blood via sodium-phosphate cotransporters.

It turns out, though, that parathyroid hormone also shuts this down.

This means that phosphate is left in the lumen and eventually gets sent out in the urine.

Now, that calcium’s still in the lumen, though, but parathyroid hormone also affects the distal convoluted tubule and increases calcium reabsorption.

So when the dust settles, as a result of parathyroid hormone, phosphate is lost in the urine while ionized calcium is kept in the blood, so ionized calcium levels rise and phosphate levels fall!

With all of this in mind, hypophosphatemia can develop a few different ways.

The first possibility is by having excess losses of phosphate.

This can result in conditions like primary hyperparathyroidism which result in too much parathyroid hormone, which leads to excess phosphate being excreted in the urine.

Another example is Fanconi syndrome, which is where the proximal convoluted tubule essentially loses its capacity to reabsorb a variety of solutes - including phosphate - once again letting it get excreted in the urine.

Another possibility is not absorbing enough through the gastrointestinal tract, because usually phosphate ions are absorbed in the GI tract, but some substances like alcohol or a medication can impair that phosphate absorption, which means it gets excreted.

This includes antacids that contain aluminum, calcium, or magnesium, all of which are positive ions that can bind with the negatively charged phosphate and block absorption.

Alternatively, a person may simply not be getting enough phosphate in the diet, although this is unusual because it’s found in nearly all foods.